Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?

Journal of Urology

Volumn 157, Issue 1, 1997, Pages 189-194

  Prestigiacomo, Anthony F ^a   Stamey, Thomas A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

prostate specific antigen; prostatic hypertrophy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0031060379     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65320-5     Document Type: Article

References (14)

1. Prestigiacomo, A. F., Lilja, H., Pettersson, K., Wolfert, R. L. and Stamey, T. A.: A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario. J. Urol., 156: 350, 1996.
2. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
3. Keetch, D. W. and Andriole, G. L.: Prostate cancer screening. Monogr. Urol., 17: 29, 1996.
4. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
5. Dietrick, D., McNeal, J. E. and Stamey, T. A.: Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume. Urology, 45: 987, 1995.
6. Terris, M. K. and Stamey, T. A.: Determination of prostate volume by transrectal ultrasound. J. Urol., 145: 984, 1991.
7. Stamey, T. A.: Second Stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994. Urology, 45: 173, 1995.
8. Luderer, A. A., Chen, Y.-T., Soriano, T. F., Kramp, W. J., Carlson, G., Cuny, C., Sharp, T., Smith, W., Petteway, J., Brawer, M. K. and Thiel, R.: Measurement of the proportion of free to total prostate-specific antigen improves the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995.
9. Chen, Y.-T., Luderer, A. A., Thiel, R. P., Carlson, G., Cuny, C. L. and Soriano, T. F.: Using proportions of free to total prostate specific antigen (PSA), age, and total PSA to predict the probability of prostate cancer. Urology, 47: 518, 1996.
10. Benson, M. C., Whang, I. S., Pantuck, A., Ring, K., Kaplan, S. A., Olsson, C. A. and Cooner, W. H.: Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol., 147: 815, 1992.
11. Hammerer, P. G., McNeal, J. E. and Stamey, T. A.: Correlation between serum PSA levels and the volume of the individual glandular zones of the human prostate. J. Urol., 153: 111, 1995.
12. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
13. Chen, Z., Chen, H. and Stamey, T. A.: Prostate specific antigen (PSA) in benign prostatic hyperplasia (BPH) tissue is different from PSA in prostate cancer (PCa) tissue. J. Urol., part 2, 155: 696A, abstract 1541, 1996.
14. Christensson, A., Laurell, C. B. and Lilja, H.: Enzymatic activity of prostate-specific antigen and its reaction with extracellular serine proteinase inhibitors. Eur. J. Biochem., 194: 755, 1990.